Emergent Biosolutions
EBS
EBS
162 hedge funds and large institutions have $629M invested in Emergent Biosolutions in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 57 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 57
4% less capital invested
Capital invested by funds: $655M → $629M (-$25.3M)
Holders
162
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$13.9M | |
| 2 | +$8.44M | |
| 3 | +$6.18M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$5.59M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$4.55M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$4.99M | |
| 3 | -$4.98M | |
| 4 |
Morgan Stanley
New York
|
-$3.2M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.62M |